ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,065Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 2094

$1.26M Total Retail Price of All Prescriptions

Rank: 41 out of 2094

422 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 422 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 422 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

3% of this provider’s 10,553 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 464 398 1 2
ENALAPRIL MALEATE 388 258 2 25
ATORVASTATIN CALCIUM 375 288 3 5
NEXIUM 357 259 4 16
SIMVASTATIN 314 217 5 1
OMEPRAZOLE 309 201 6 4
METOPROLOL SUCCINATE 300 250 7 9
METFORMIN HCL 296 161 8 8
FUROSEMIDE 295 242 9 6
LEVOTHYROXINE SODIUM 280 219 10 3
CRESTOR 262 182 11 15
LOVAZA 218 113 12 53
ZOLPIDEM TARTRATE 207 133 13 14
CLOPIDOGREL 181 147 14 22
DIOVAN HCT 176 150 15 28
LIDODERM 173 96 16 59
ENDOCET 160 72 S2 17 88
METOPROLOL TARTRATE 160 130 17 10
GLIMEPIRIDE 156 115 19 31
DONEPEZIL HCL 155 152 20 20
ADVAIR DISKUS 149 114 21 36
BYSTOLIC 148 97 22 83
PROAIR HFA 146 111 23 45
PLAVIX 145 123 24 38
CARVEDILOL 144 130 25 19
PRAVASTATIN SODIUM 141 88 26 18
POTASSIUM CHLORIDE 141 104 26 24
CYCLOBENZAPRINE HCL 141 63 R 26 115
GABAPENTIN 133 68 29 23
DIOVAN 129 107 30 13
ATELVIA 128 103 31 135
DIGOXIN 116 103 32 51
GLYBURIDE-METFORMIN HCL 116 84 R 32 94
TAMSULOSIN HCL 114 79 34 29
AZITHROMYCIN 108 64 35 27
HYDROCHLOROTHIAZIDE 107 74 36 12
CELEBREX 102 94 37 74
LISINOPRIL 98 69 38 7
LANTUS SOLOSTAR 94 47 39 76
ALENDRONATE SODIUM 93 77 40 30
GLYBURIDE 90 32 R 41 95
CLOTRIMAZOLE-BETAMETHASONE 89 48 42 91
NAMENDA 88 88 43 32
LOSARTAN-HYDROCHLOROTHIAZIDE 88 65 43 52
AMOX TR-POTASSIUM CLAVULANATE 85 41 45 107
TRAMADOL HCL 84 40 46 33
MIRTAZAPINE 83 58 47 43
SPIRIVA 80 64 48 60
SINGULAIR 80 54 48 64
WARFARIN SODIUM 79 61 50 11
LOSARTAN POTASSIUM 78 74 51 17
OXYCODONE HCL-ACETAMINOPHEN 78 57 S2 51 119
IBUPROFEN 77 35 53 73
FLUTICASONE PROPIONATE 75 40 54 41
AMLODIPINE BESYLATE-BENAZEPRIL 73 61 55 58
MELOXICAM 72 59 56 49
OXYCODONE-ACETAMINOPHEN 71 44 S2 57 40
CYMBALTA 70 29 58 61
CLONIDINE HCL 69 56 59 62
RANITIDINE HCL 65 48 60 80
HYDROCODONE-ACETAMINOPHEN 63 28 S3 61 42
LYRICA 62 34 62 85
AMITRIPTYLINE HCL 60 52 R 63 178
BIDIL 59 49 64 234
UNIFINE PENTIPS 57 30 65 257
LEVOFLOXACIN 56 40 66 70
VOLTAREN 56 42 66 109
PANTOPRAZOLE SODIUM 56 38 66 37
MILRINONE LACTATE 55 55 10 69 504
AVODART 54 29 70 163
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 33 71 55
SYMBICORT 52 37 72 149
JALYN 52 47 72 360
ATENOLOL 52 52 72 21
JANUVIA 51 33 75 35
AZOR 50 24 76 155
QUETIAPINE FUMARATE 50 16 76 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.